Potential Upside 1 Yr
98.40 %
Target
Current Price
Strong Buy
Mean Recos by 3 Analysts
4/10
Stock Score
- EarningsNR
- Fundamentals8
- Relative Valuation4
- Risk1
- Price Momentum5
Potential Upside 1 Yr
48.60 %
Target
Current Price
Buy
Mean Recos by 3 Analysts
8/10
Stock Score
- Earnings9
- Fundamentals8
- Relative Valuation4
- Risk8
- Price Momentum5
Potential Upside 1 Yr
44.30 %
Target
Current Price
Strong Buy
Mean Recos by 4 Analysts
6/10
Stock Score
- Earnings3
- Fundamentals3
- Relative Valuation5
- Risk9
- Price Momentum8
Potential Upside 1 Yr
38.60 %
Target
Current Price
Buy
Mean Recos by 11 Analysts
9/10
Stock Score
- Earnings7
- Fundamentals9
- Relative Valuation3
- Risk9
- Price Momentum9
Potential Upside 1 Yr
38.10 %
Target
Current Price
Hold
Mean Recos by 7 Analysts
8/10
Stock Score
- Earnings3
- Fundamentals9
- Relative Valuation8
- Risk7
- Price Momentum7
Potential Upside 1 Yr
35.80 %
Target
Current Price
Strong Buy
Mean Recos by 7 Analysts
4/10
Stock Score
- Earnings1
- Fundamentals1
- Relative Valuation2
- Risk8
- Price Momentum9
Potential Upside 1 Yr
33.90 %
Target
Current Price
Buy
Mean Recos by 25 Analysts
9/10
Stock Score
- Earnings6
- Fundamentals6
- Relative Valuation7
- Risk10
- Price Momentum9
Potential Upside 1 Yr
32.40 %
Target
Current Price
Strong Buy
Mean Recos by 4 Analysts
6/10
Stock Score
- Earnings3
- Fundamentals5
- Relative Valuation1
- Risk9
- Price Momentum10
Potential Upside 1 Yr
26.40 %
Target
Current Price
Hold
Mean Recos by 3 Analysts
1/10
Stock Score
- Earnings1
- Fundamentals1
- Relative Valuation6
- Risk4
- Price Momentum2
Potential Upside 1 Yr
25.40 %
Target
Current Price
Hold
Mean Recos by 19 Analysts
7/10
Stock Score
- Earnings6
- Fundamentals5
- Relative Valuation5
- Risk10
- Price Momentum6
- Home
- Markets Live
- Stocks
- Upside Radar by Sectors
- Pharmaceuticals